⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL586397 | 0.82 | TP53 (0.39) | — | |
| SCHEMBL21315707 | 0.77 | GABRA1 (0.35) | — | |
| SCHEMBL31413695 | 0.77 | KDM4E (0.37) | — | |
| SCHEMBL25493617 | 0.76 | TP53 (0.38) | — | |
| SCHEMBL379708 | 0.75 | KDM4E (0.32) | — | |
| Charcoal, Activated SCHEMBL30558882 | 0.73 | KDM4E (0.31) | — | |
| SCHEMBL29522058 | 0.72 | — | — | |
| SCHEMBL5553224 | 0.72 | — | — | |
| SCHEMBL16741960 | 0.72 | CCR1 (0.33) | — | |
| SCHEMBL11349621 | 0.72 | HSP90AA1 (0.37) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2591674-B1 | Heterocyclic compounds as pest controllers | BAYER CROPSCIENCE AG (DE) | 2016-01-13 | — | — | EP | claimed |
| US-9221042-B2 | Metal complexes, especially the ruthenium complexes, and use thereof | APEIRON SYNTHESIS S.A. (PL) | 2015-12-29 | — | — | US | claimed |
| CN-115703802-A | Boron-containing organic compound and application thereof | 北京鼎材科技有限公司 | 2023-02-17 | — | — | CN | disclosed |
| CN-115463219-A | Pharmaceutical composition containing beta-lactam compound and application thereof | 中国医学科学院医药生物技术研究所 | 2022-12-13 | — | — | CN | disclosed |
| CN-115244723-A | Organic electroluminescent device | 默克专利有限公司 | 2022-10-25 | — | — | CN | disclosed |
| US-10980835-B2 | Arsenic trioxide for treatment of PIN1-associated disorders | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. (US) | 2021-04-20 | — | — | US | disclosed |
| WO-2020117867-A1 | DARINAPARSIN AND RETINOIC ACID COMPOUNDS FOR TREATMENT OF IDH-ASSOCIATED DISORDERS | BETH ISRAEL-DEACONESS MEDICAL CENTER, INC. (US) | 2020-06-11 | — | — | WO | disclosed |
| WO-2020117868-A1 | ARSENIC COMPOUNDS AND RETINOIC ACID COMPOUNDS FOR TREATMENT OF IDH-ASSOCIATED DISORDERS | BETH ISRAEL-DEACONESS MEDICAL CENTER, INC. (US) | 2020-06-11 | — | — | WO | disclosed |
| US-10548864-B2 | Enhanced ATRA-related compounds for the treatment of proliferative diseases, autoimmune diseases, and addiction conditions | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. (US) | 2020-02-04 | — | — | US | disclosed |
| WO-2019182015-A1 | ALGINIC ACID DERIVATIVE BONDED TO NONSTEROIDAL ANTI-INFLAMMATORY COMPOUND | 持田製薬株式会社 | 2019-09-26 | — | — | WO | disclosed |
| US-10265288-B2 | Methods and compositions for the treatment of proliferative disorders | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. (US) | 2019-04-23 | — | — | US | disclosed |
| US-9439884-B2 | Methods for the treatment of immune disorders | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. (US) | 2016-09-13 | — | — | US | disclosed |
| US-20150044278-A1 | METHODS AND COMPOSITIONS FOR THE TREATMENT OF PROLIFERATIVE DISORDERS | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 2015-02-12 | — | — | US | disclosed |
| US-20140219957-A1 | METHODS AND COMPOSITIONS FOR THE TREATMENT OF IMMUNE DISORDERS | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. (US) | 2014-08-07 | — | — | US | disclosed |
| CN-103702967-A | Methods and compositions for treatment of proliferative disorders | BETH ISRAEL HOSPITAL | 2014-04-02 | — | — | CN | disclosed |
| US-20140086909-A1 | METHODS AND COMPOSITIONS FOR THE TREATMENT OF PROLIFERATIVE DISORDERS | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. (US) | 2014-03-27 | — | — | US | disclosed |
| WO-2012162698-A1 | METHODS AND COMPOSITIONS FOR THE TREATMENT OF IMMUNE DISORDERS | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. (US) | 2012-11-29 | — | — | WO | disclosed |
| WO-2012037258-A1 | PROCESSES FOR PREPARING 1,2-SUBSTITUTED CYCLOPROPYL DERIVATIVES | ABBOTT LABORATORIES (US) | 2012-03-22 | — | — | WO | disclosed |
| EP-1533292-B1 | DIBENZYLAMINE COMPOUND AND MEDICINAL USE THEREOF | JAPAN TOBACCO INC (JP) | 2007-02-14 | — | — | EP | disclosed |
| US-20040266764-A1 | Hydroxamic acid derivatives | HANNAH DUNCAN ROBERT | 2004-12-30 | — | — | US | disclosed |